4-chloro-6-methyl-5-phenylthieno[2,3-d]pyrimidine, 95.0%, 250mg

1-(3-Nitrophenyl)-piperazine, 90.0%, 5g

1-(2-Fluorophenyl)pentan-2-one, 97.0%, 1g

2,4,6-TRIMETHYL-N-(2-(TRIFLUOROMETHYL)PHENYL)BENZENESULFONAMIDE, 97%, 50mg

8-Chloroquinoline-5-carboxylic acid, 95.0%, 1g

4-bromo-6-nitro-1H-1,3-benzodiazole, 98%, 1g

(3-Chloromethyl-phenyl)acetic acid, 96.0%, 1g

Potassium formate, min. 98%, for synthesis, 1 kg, plastic packaging.

1-Bromo-3-chloro-2,4-difluorobenzene, 95.0%, 1g

3-Cyano-1H-pyrrole-2-carboxylic acid, 95%, 250mg

1-acetyl-1H-indole-2,3-dione, 98.0%, 100g

(Z)-6-fluoro-3-((1-methyl-1H-1,2,4-triazol-5-yl)methylene)-4-nitroisobenzofuran-1(3H)-one, 98%, 250mg

2-OXIRANECARBOXYLIC ACID, 2-[6-(4-CHLOROPHENOXY)HEXYL]-, ETHYL ESTER, (2R)-, 95%, 250mg